183 related articles for article (PubMed ID: 21468013)
21. Refractory celiac disease: epidemiology and clinical manifestations.
Malamut G; Cellier C
Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
[TBL] [Abstract][Full Text] [Related]
22. Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease.
Gross S; Bakker SF; van Bodegraven AA; van Hoogstraten IM; Gelderman KA; Bouma G; Mulder CJ; von Blomberg BM; Bontkes HJ
J Gastrointestin Liver Dis; 2014 Jun; 23(2):127-33. PubMed ID: 24949603
[TBL] [Abstract][Full Text] [Related]
23. [Jejunal ulcerations - a diagnostic challenge in a patient with coeliac disease].
Weber M; Schumann M; Felber J; Mireskandari M; Schmidt C; Stallmach A
Z Gastroenterol; 2015 Nov; 53(11):1261-6. PubMed ID: 26562400
[TBL] [Abstract][Full Text] [Related]
24. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
25. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
26. Is refractory celiac disease more severe in old Europe?
Malamut G; Cellier C
Am J Gastroenterol; 2011 May; 106(5):929-32. PubMed ID: 21540899
[TBL] [Abstract][Full Text] [Related]
27. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.
Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G
Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565
[TBL] [Abstract][Full Text] [Related]
29. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
30. Video capsule endoscopy in patients with nonresponsive celiac disease.
Van Weyenberg SJ; Smits F; Jacobs MA; Van Turenhout ST; Mulder CJ
J Clin Gastroenterol; 2013; 47(5):393-9. PubMed ID: 23164686
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical and T-cell receptor gene rearrangement analyses as predictors of morbidity and mortality in refractory celiac disease.
Arguelles-Grande C; Brar P; Green PH; Bhagat G
J Clin Gastroenterol; 2013 Aug; 47(7):593-601. PubMed ID: 23470642
[TBL] [Abstract][Full Text] [Related]
33. Capsule endoscopy in refractory celiac disease.
Daum S; Wahnschaffe U; Glasenapp R; Borchert M; Ullrich R; Zeitz M; Faiss S
Endoscopy; 2007 May; 39(5):455-8. PubMed ID: 17516353
[TBL] [Abstract][Full Text] [Related]
34. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
35. Results from the German registry for refractory celiac disease.
Weber M; Wolf N; Branchi F; Tangermann P; Itzlinger A; Poralla L; Preiß JC; Grunert P; Daum S; Siegmund B; Stallmach A; Schumann M
Z Gastroenterol; 2021 Sep; 59(9):944-953. PubMed ID: 34507373
[TBL] [Abstract][Full Text] [Related]
36. Cellular and molecular bases of refractory celiac disease.
Soderquist CR; Bhagat G
Int Rev Cell Mol Biol; 2021; 358():207-240. PubMed ID: 33707055
[TBL] [Abstract][Full Text] [Related]
37. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
38. Refractory celiac disease.
Rishi AR; Rubio-Tapia A; Murray JA
Expert Rev Gastroenterol Hepatol; 2016; 10(4):537-46. PubMed ID: 26603931
[TBL] [Abstract][Full Text] [Related]
39. Value of biopsy in a cohort of children with high-titer celiac serologies: observation of dynamic policy differences between Europe and North America.
Badizadegan K; Vanlandingham DM; Hampton W; Thompson KM
BMC Health Serv Res; 2020 Oct; 20(1):962. PubMed ID: 33081760
[TBL] [Abstract][Full Text] [Related]
40. Refractory celiac disease.
Malamut G; Murray JA; Cellier C
Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
